Robert M. Janosky
Corporate Officer/Principal at SATSUMA PHARMACEUTICALS, INC.
Profile
Robert M.
Janosky is currently the Chief Commercial Officer at Satsuma Pharmaceuticals, Inc. Prior to this, he worked as the VP of Business Development & Strategic Planning at DURECT Corp.
from 2016 to 2020.
He received his undergraduate degree from the University of Vermont and his MBA from the University of Rochester Simon Business School.
Robert M. Janosky active positions
| Companies | Position | Start |
|---|---|---|
| SATSUMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2020-03-04 |
Former positions of Robert M. Janosky
| Companies | Position | End |
|---|---|---|
| DURECT CORPORATION | Corporate Officer/Principal | 2020-02-29 |
Training of Robert M. Janosky
| University of Vermont | Undergraduate Degree |
| University of Rochester Simon Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DURECT CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company was founded by John Kollins on June 21, 2016 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Robert M. Janosky
